Oncostatin M in the anti-inflammatory response

Annals of the Rheumatic Diseases

Volumn 60, Issue SUPPL. 3, 2001, Pages

  Wahl, A F ^a   Wallace, P M ^a  

^a SEATTLE GENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; ONCOSTATIN M;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEPSIS; T LYMPHOCYTE; WOUND HEALING;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BACTERIAL INFECTIONS; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MICE; MODELS, ANIMAL; MULTIPLE SCLEROSIS; ONCOSTATIN M; PEPTIDES; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 0034775793     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Role of cytokines in rheumatoid arthritis
2. A perspective on anti-cytokine and anti-T cell-directed therapies in rheumatoid arthritis
3. Monoclonal antibody therapy of inflammatory rheumatic diseases
4. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to listeria monocytogenes and Leishmania major infections
5. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins
6. Inhibitory cytokines and cytokine inhibitors
7. In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis
8. Transcending conventional therapies: The role of biologic and other novel therapies
9. Multiple sclerosis: TNF revisited, with promise
10. Immunosuppressive and anti-inflammatory properties of interleukin 10
11. Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells
12. The role of oncostatin M in the acute phase response
13. Interleukin-6 family of cytokines and gp130
14. Oncostatin M
15. Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M
16. Regulation of IL-6 expression by oncostatin M
17. In vivo properties of oncostatin M
18. Regulation of inflammatory responses by oncostatin M
19. Collagen-induced arthritis in mice: Synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen
20. The effect of an interleukin-1 receptor antagonist protein on type II-induced arthritis and antigen-induced arthritis in mice
21. Mouse oncostatin M: An immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway
22. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice
23. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice
24. Interleukin-1, tumor necrosis factor and their specific inhibitors
25. Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts
26. Interleukin-8, a chemotactic and inflammatory cytokine
27. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
28. 1-acid glycoprotein against tumor necrosis factor-induced lethality
29. Acute-phase proteins in inflammation
30. Effect of recombinant human interleukin-11 on rat megakaryopoiesis and thrombopoiesis in vivo: Comparative study with interleukin-6
31. 2 in mice
32. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1
33. Cytokine-regulated proteases in autoimmune diseases
34. Inhibition of human neutrophil superoxide generation by α1-antichymotrypsin
35. Stimulatory effect of inflammatory cytokines on alpha 1- antichymotrypsin expression in human lung-derived epithelial cells
36. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth
37. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture
38. Stimulation of TIMP-1 production by oncostatin M in human articular cartilage
39. Regulation of alpha 1-antichymotrypsin synthesis in cells of epithelial origin
40. Interleukin 6 in diseases: Cause or cure?
41. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
42. Defective inflammatory response in interleukin 6-deficient mice
43. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules
44. Oncostatin M: A novel regulator of endothelial cell properties
45. Esculetin inhibits cartilage resorption induced by interleukin 1α in combination with oncostatin M
46. Oncostatin-M: A new bone active cytokine that activates osteoblasts and inhibits bone resorption
47. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo
48. Cloning and characterization of a specific receptor for mouse oncostatin M
49. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation